Sunday, September 7, 2025

MediPharm Labs Posts Q3 Revenues of $5.4 Million, Continues To Post Negative Gross Margins

MediPharm Labs (TSX: LABS) this morning reported its third quarter financial results, posting revenues of $5.4 million for the quarter. The firm also posted a net loss of $7.4 million for the period.

Revenues were effectively flat for the the quarter, climbing from $5.1 million to $5.4 million on a quarter over quarter basis, while the firm still looks to improve upon its first quarter revenue figure of $5.5 million. Gross profit was again negative, a trend that has occurred all year, with the company posting a gross loss of $1.9 million.

Operating expenses further added to the losses, with general administrative expenses coming in at $4.6 million followed by marketing and selling expenses of $0.9 million. The firm overall posted an operating loss of $7.5 million, which resulted in a net loss of $7.5 million after a small $0.1 million income tax recovery.

Adjusted EBITDA meanwhile amounted to a loss of $5.6 million.

The firm also noted that its new CEO, Bryan Howcroft, is expected to start today, which is expected to improve international and pharmaceutical sales growth.

MediPharm Labs last traded at $0.315 on the TSX.


.Information for this briefing was found via Sedar and Medipharm Labs. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Orla Mining Q2 Earnings: Musselwhite Changes Everything

Endeavour Silver Q2 Earnings: Growth Isn’t Always Pretty

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Recommended

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos

Related News

Medipharm Labs Scrambles To Instill Investor Confidence

Medipharm Labs (TSX: LABS) appears to be scrambling to quell investor fears, releasing an update...

Thursday, January 30, 2020, 08:29:16 AM

Medipharm Labs Sees PI Financial, Mackie Research Drop Estimates, Price Targets

Medipharm Labs (TSX: LABS) reported Q1 2020 results on Thursday, June 18, which showed it’s...

Friday, June 19, 2020, 02:55:31 PM

Medipharm Labs Announces White Label Agreement, Provides No Details

Medipharm Labs (TSX: LABS) has entered into its second white label supply agreement with its...

Monday, May 4, 2020, 08:24:41 AM

Medipharm Labs Reports Revenues of $31 million for Second Quarter

Medipharm Labs (TSX: LABS) filed its second quarter earnings after the bell this evening, reporting...

Monday, August 12, 2019, 05:35:41 PM

MediPharm Labs Report sees Quarterly Revenue Drop 25%

This morning MediPharm Labs (TSX: LABS) released their fourth quarter results for the year ended...

Monday, March 30, 2020, 09:40:29 AM